Drugs / Daclinza
last change Jun 2017 re-read 2 minutes ago

Daclinza

Developed for
chronic hepatitis C virus infection
Investigated by
Pusan National University Hospital

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02639585 Dec 2015 → Feb 2017 chronic hepatitis C virus infection Pusan National University Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Daclinza ClinicalTrials.gov intervention name — accepted as the source's own label NCT02639585